Last reviewed · How we verify
Cecolin
At a glance
| Generic name | Cecolin |
|---|---|
| Sponsor | Xiamen Innovax Biotech Co., Ltd |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Post-marketing Observational Database Study Monitoring the Safety of CecolinⓇ
- Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls (PHASE3)
- Immunogenicity and Safety of One Dose of HPV Vaccine (PHASE4)
- Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity
- Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female (PHASE4)
- Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |